Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Larson

Showing results (21-30 of 383) with videos related to

Pageof 39
Sort By:
Expert Opinion on Pharmacotherapy|August 24, 2006
Nelarabine in the treatment of refractory T-cell malignant diseasesJustin Kline, Richard A Larson
Blood Advances|December 28, 2018
Imatinib is still recommended for frontline therapy for CMLAndrew Hantel, Richard A Larson
Current Opinion in Hematology|June 12, 2003
Progress and challenges in the therapy of adult acute lymphoblastic leukemiaPartow Kebriaei, Richard A Larson
Current Opinion in Oncology|August 29, 2009
Role of allogeneic hematopoietic cell transplantation in adults with acute lymphoblastic leukemiaRyan J Mattison, Richard A Larson
Best Practice & Research. Clinical Haematology|November 30, 2019
Post-remission therapy in acute myeloid leukemia: Are we ready for an individualized approach?Benjamin A Derman, Richard A Larson
Expert Opinion on Pharmacotherapy|December 1, 2005
Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a reviewJustin P Kline, Richard A Larson
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 30, 2017
Pepsi® or Coke®? Influence of acid on dasatinib absorptionRandall W Knoebel, Richard A Larson
Seminars in Oncology|August 12, 2008
Therapy-related myeloid leukemiaLucy A Godley, Richard A Larson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2014
Positron Emission Tomography-Computed Tomography Imaging of a Patient With Several Myeloid Sarcomas With FLT3-ITD and NPM1 MutationsGottfried von Keudell, Richard A Larson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2014
Dasatinib-Related Pulmonary Toxicity Mimicking an Atypical InfectionJagoda K Jasielec, Richard A Larson
Pageof 39

Showing results (21-30 of 383) with videos related to

Sort By:
Pageof 39
Expert Opinion on Pharmacotherapy|August 24, 2006
Nelarabine in the treatment of refractory T-cell malignant diseasesJustin Kline, Richard A Larson
Blood Advances|December 28, 2018
Imatinib is still recommended for frontline therapy for CMLAndrew Hantel, Richard A Larson
Current Opinion in Hematology|June 12, 2003
Progress and challenges in the therapy of adult acute lymphoblastic leukemiaPartow Kebriaei, Richard A Larson
Current Opinion in Oncology|August 29, 2009
Role of allogeneic hematopoietic cell transplantation in adults with acute lymphoblastic leukemiaRyan J Mattison, Richard A Larson
Best Practice & Research. Clinical Haematology|November 30, 2019
Post-remission therapy in acute myeloid leukemia: Are we ready for an individualized approach?Benjamin A Derman, Richard A Larson
Expert Opinion on Pharmacotherapy|December 1, 2005
Clofarabine in the treatment of acute myeloid leukaemia and acute lymphoblastic leukaemia: a reviewJustin P Kline, Richard A Larson
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|December 30, 2017
Pepsi® or Coke®? Influence of acid on dasatinib absorptionRandall W Knoebel, Richard A Larson
Seminars in Oncology|August 12, 2008
Therapy-related myeloid leukemiaLucy A Godley, Richard A Larson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 16, 2014
Positron Emission Tomography-Computed Tomography Imaging of a Patient With Several Myeloid Sarcomas With FLT3-ITD and NPM1 MutationsGottfried von Keudell, Richard A Larson
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2014
Dasatinib-Related Pulmonary Toxicity Mimicking an Atypical InfectionJagoda K Jasielec, Richard A Larson
Pageof 39